EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes

Mohsen Ghaferi, Seyed Ebrahim Alavi iD, Khanh Phan, Howard Maibach, Yousuf Mohammed iD

Molecular Pharmaceutics · 04.11.2024 · 21 (11) · 5373-5391

DOI: 10.1021/acs.molpharmaceut.4c00211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 04.10.2024. Verfasst von Mohsen Ghaferi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Islamic Azad University, Shahrood Branch, Shahrood, Semnan 9WVR+757, Iran. Hauptthemen laut MEDLINE: Administration, Cutaneous, Drug Delivery Systems. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 215 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transdermal drug delivery systems (TDDS), commonly refered to as "patches", present a nonintrusive technique to provide medication without the need for invasive procedures. These products adhere to the skin and gradually release a specific dosage of medicine at a defined rate into the bloodstream. Compared with other methods of drug delivery, TDDS offer benefits such as reduced invasiveness, convenience for patients, and avoidance of the metabolic processes that occur when drugs are orally consumed. Throughout time, TDDS have been used to provide medications for various medical conditions (such as nicotine, fentanyl, nitroglycerin, and clonidine), and their potential for delivering biologics is currently being explored. This review investigates the current literature on the drug delivery efficacy of medical TDDS through the transdermal route. Additionally, the review addresses potential risks and failure modes associated with TDDS design and development as well as strategies for mitigating such risks. A thorough understanding of failure modes provides a blueprint to mitigate failure and produce high-quality efficacious therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, CutaneousDrug Delivery SystemsHumansFentanylTransdermal PatchSkinSkin AbsorptionClonidineAnimalsNicotineNitroglycerin

Stichwörter der Autor:innen

critical quality attributesfailure modesmanufacturing issuesquality by designtransdermal drug delivery systemswearable patches

Substanzen

FentanylClonidineNicotineNitroglycerin

Autor:innen und Institutionen

  • Department of Chemical Engineering, Islamic Azad University, Shahrood Branch, Shahrood, Semnan 9WVR+757, Iran.
  • Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, Queensland 4102, Australia.
  • University of California, San Francisco, San Francisco, California 94115, United States.
  • School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.

ORCID-Profile: Seyed Ebrahim Alavi, Yousuf Mohammed

Zitieren

APA

Ghaferi, M., Alavi, S. E., Phan, K., Maibach, H., & Mohammed, Y. (2024). Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes. Molecular Pharmaceutics, 21(11), 5373-5391. https://doi.org/10.1021/acs.molpharmaceut.4c00211

Vancouver

Ghaferi M, Alavi SE, Phan K, Maibach H, Mohammed Y. Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes. Molecular Pharmaceutics. 2024;21(11):5373-5391. doi:10.1021/acs.molpharmaceut.4c00211

BibTeX
@article{Ghaferi2024,
  author = {Ghaferi, Mohsen and Alavi, Seyed Ebrahim and Phan, Khanh and Maibach, Howard and Mohammed, Yousuf},
  title = {Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {11},
  pages = {5373--5391},
  doi = {10.1021/acs.molpharmaceut.4c00211}
}
Kostenlos starten →